SynthesisAIDS research and therapy2016

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials.

Junjun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.